Otsuka Pharmaceutical Expands Babi Mild to Target 50+ Market with New Line
Economy

Otsuka Pharmaceutical Expands Babi Mild to Target 50+ Market with New Line

Thai consumer goods giant Otsuka Pharmaceutical has launched a new product line, "Babi Mild & Beyond Immortelle," under its Babi Mild brand. This move signals a strategy to expand beyond traditional baby care and target consumers aged 50 and above.

This article requires PRO

This article is outside the free access window or is a special report. PRO unlocks it and the full archive.